Biotech · Private company
The Medicines Company
Track this companyFree. Adds The Medicines Company to your Dealase workspace and tells you when its record changes.
Clinical trials110 recruiting or active
Pipeline programs15From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline15
- InclisiranPhase 3 · Heterozygous Familial HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- Inclisiran SodiumPhase 3 · ASCVDClinicalTrials.gov · fetched Nov 12, 2026
- Stage 1: Clevidipine (double-blinded)Phase 3 · DyspneaClinicalTrials.gov · fetched Nov 12, 2026
- Stage 2: Clevidipine (open-label)Phase 3 · DyspneaClinicalTrials.gov · fetched Nov 12, 2026
- ALN-PCSSCPhase 2 · Atherosclerotic Cardiovascular DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ALN-PCSSCPhase 2 · Homozygous Familial HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- CangrelorPhase 2 · Coronary Artery Disease (CAD)ClinicalTrials.gov · fetched Nov 12, 2026
- ClopidogrelPhase 2 · Coronary Artery Disease (CAD)ClinicalTrials.gov · fetched Nov 12, 2026
- PrasugrelPhase 2 · Coronary Artery Disease (CAD)ClinicalTrials.gov · fetched Nov 12, 2026
- DextrosePhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- OritavancinPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- bivalirudinHeparin-Induced ThrombocytopeniaClinicalTrials.gov · fetched Nov 12, 2026
- OritavancinSkin Diseases, BacterialClinicalTrials.gov · fetched Nov 12, 2026
- OritavancinAcute Bacterial Skin and Skin Structure InfectionClinicalTrials.gov · fetched Nov 12, 2026
- WarfarinAcute Bacterial Skin and Skin Structure InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein CholesterolPHASE3 · COMPLETED · started Dec 21, 2017ClinicalTrials.gov NCT03399370 · fetched Nov 12, 2026
- Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH)PHASE3 · COMPLETED · started Nov 28, 2017ClinicalTrials.gov NCT03397121 · fetched Nov 12, 2026
- Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure InfectionPHASE4 · COMPLETED · started Jan 24, 2017ClinicalTrials.gov NCT02925416 · fetched Nov 12, 2026
- A Study of ALN-PCSSC in Participants With Homozygous Familial Hypercholesterolemia (HoFH)PHASE2 · COMPLETED · started Dec 13, 2016ClinicalTrials.gov NCT02963311 · fetched Nov 12, 2026
- Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)PHASE2 · COMPLETED · started Jan 1, 2016ClinicalTrials.gov NCT02597127 · fetched Nov 12, 2026
- A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)PHASE4 · COMPLETED · started Sep 29, 2015ClinicalTrials.gov NCT02452918 · fetched Nov 12, 2026
- Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a New Formulation of Oritavancin in Healthy VolunteersPHASE1 · COMPLETED · started Jul 1, 2015ClinicalTrials.gov NCT02471690 · fetched Nov 12, 2026
- Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHFPHASE3 · WITHDRAWN · started Aug 1, 2014ClinicalTrials.gov NCT04592380 · fetched Nov 12, 2026
- Cangrelor to Clopidogrel or Prasugrel Transition StudyPHASE2 · COMPLETED · started Dec 2, 2013ClinicalTrials.gov NCT01979445 · fetched Nov 12, 2026
- Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid HemorrhagePHASE2 · TERMINATED · started Jun 1, 2009ClinicalTrials.gov NCT00978822 · fetched Nov 12, 2026
- Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) PatientsPHASE4 · WITHDRAWN · started Sep 1, 2008ClinicalTrials.gov NCT00759083 · fetched Nov 12, 2026